Funicular Funds, Cable Car Capital stake 5.2% in Nasus Pharma (NSRX)
Rhea-AI Filing Summary
Nasus Pharma Ltd reports beneficial ownership disclosures. Funicular Funds, LP; Cable Car Capital, LP; and Jacob Ma-Weaver each report beneficial ownership of 612,913 Ordinary Shares, representing 5.2% of the class. The calculation uses 11,710,808 Shares outstanding as of March 27, 2026 per the Post-Effective Amendment No. 1 to Form F-1. Cable Car Capital, LP is identified as general partner of Funicular Funds and Ma-Weaver is the managing member and therefore may be deemed the beneficial owner of the shares held by Funicular Funds.
Positive
- None.
Negative
- None.
Insights
Multiple affiliated entities report the same 5.2% stake in Nasus Pharma Ltd.
The filing lists 612,913 shares each for Funicular Funds, Cable Car Capital, LP, and Jacob Ma-Weaver, tied to a single holding vehicle. The disclosure clarifies ownership through a general partner relationship and an individual managing member, which is standard attribution language for pooled‑investment structures.
Watch subsequent filings for any change in reported ownership or conversion of holdings; timing and cash‑flow treatment are not included in this excerpt.
Schedule 13G disclosure filed to report >5% position under passive/beneficial ownership rules.
The submission cites the issuer's Post-Effective Amendment No. 1 to Form F-1 as the basis for the 11,710,808 shares outstanding denominator. The filing attributes sole voting and dispositive power for the reported shares to the named filers.
Filing signatures are dated 04/07/2026; subsequent amendments or Form 13D would be required if the parties take active steps to influence control.